228 participants
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2026-09-01
- Completion:
- 2029-09-01
Conditions
- Chimeric Antigen Receptor T-cell Therapy
- B Cell Acute Lymphoblastic Leukemia (B-ALL)
- B Cell Lymphoma
- Antibiotic Prophylaxis
- Immunoglobulin Therapy
Interventions
- DRUG
No Results Yet